PALI
Palisade Bio, Inc.
Palisade Bio, Inc. insider trading
Insiders at Palisade Bio, Inc. have been buying its stock on the open market. The largest purchase in the last 30 days was Williams Donald Allen (Director) buying $14.6K of PALI, filed Oct 05, 2026. Every open-market purchase and sale its officers, directors and 10% owners filed in that time is listed below, each linked to the original Form 4.
- Bought on the open market
- $28.8K
- Sold
- —
- Insiders
- 1
- Latest trade
- Oct 02, 2026
From SEC filings · last 30 days
Recent PALI insider transactions
SEC Form 4 data, Q3 2024 to Q2 2026
PALI insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, 3 insiders traded PALI on the open market: 2 purchases worth $17.8K and 2 sales worth $10.3K. In the last four quarters alone: 2 purchases ($17.8K) and 2 sales ($10.3K), by 3 insiders.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | — | — | |
| Q1 2026 | +$17.8K2 buys | −$10.3K2 sales | |
| Q4 2025 | — | — | |
| Q3 2025 | — | — | |
| Q2 2025 | — | — | |
| Q1 2025 | — | — | |
| Q4 2024 | — | — | |
| Q3 2024 | — | — |
- Largest purchase
- +$9.4K of PALI by Williams Donald Allen (Director) on Jan 09, 2026.
- Largest sale
- −$6.8K of PALI by Finley John David (CEO, CFO · Director) on Feb 12, 2026.
Open-market transactions through Jun 30, 2026most recent first
Finley John David
CEO, CFO · Director
−$6.8K
Feb 12, 2026
3,896 sh · $1.75
Jones Mitchell Lawrence
Chief Medical Officer
−$3.5K
Feb 12, 2026
1,989 sh · $1.75
Williams Donald Allen
Director
+$8.4K
Jan 16, 2026
5,000 sh · $1.67
Williams Donald Allen
Director
+$9.4K
Jan 09, 2026
5,000 sh · $1.88
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Feb 12, 2026 | Finley John DavidCEO, CFO · Director | 3,896 | $1.75 | −$6.8K |
| Feb 12, 2026 | Jones Mitchell LawrenceChief Medical Officer | 1,989 | $1.75 | −$3.5K |
| Jan 16, 2026 | Williams Donald AllenDirector | 5,000 | $1.67 | +$8.4K |
| Jan 09, 2026 | Williams Donald AllenDirector | 5,000 | $1.88 | +$9.4K |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
Don't check PALI — let it ping you
Watch every insider filing the minute it clears the SEC
The live dashboard reads every Form 4 as it lands and puts it in plain English — open-market buys, cluster buys where several insiders move at once, and the sales executives chose to make rather than scheduled. Free to open; Pro adds alerts, watchlists and each buyer's track record.
Palisade Bio, Inc. is outside the 777 companies InsiderPulse scans continuously. This page is built from the filings on the live tape and stays up while its insiders are buying. Monitoring, not advice.
Other companies insiders are buying now
Questions
- Are PALI insiders buying or selling?
- Between Oct 01, 2026 and Oct 02, 2026, 1 Palisade Bio, Inc. insider made 2 open-market purchases worth $28.8K and no sales, a net purchase of $28.8K.
- How much PALI stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 3 Palisade Bio, Inc. insiders made 2 open-market purchases worth $17.8K and 2 sales worth $10.3K. In the four quarters to Jun 30, 2026: 2 purchases ($17.8K) and 2 sales ($10.3K). The largest purchase was Williams Donald Allen buying $9.4K on Jan 09, 2026. The largest sale was Finley John David selling $6.8K on Feb 12, 2026.
- What was the largest recent PALI insider trade?
- Williams Donald Allen (Director) bought $14.6K of PALI stock on Oct 02, 2026 at about $1.46 a share.
- When did an insider last buy PALI shares?
- The most recent open-market purchase on file is Williams Donald Allen (Director) buying $14.6K on Oct 02, 2026.
- Where does PALI insider trading data come from?
- From the Form 4 filings Palisade Bio, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.